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Background
Hereditary non-polyposis colorectal cancer (HNPCC) is
a hereditary cancer syndrome in which confirmed car-
riers of a gene mutation are at high risk for colorectal
(CRC) and extracolonic cancers. The purpose of the
current study was to develop a greater understanding of
the factors influencing the decision-making of confirmed
HNPCC carriers post-genetic testing about screening
and disease management.
Methods
The study used a grounded theory approach to data
collection and analysis as part of a multiphase project
examining the psychosocial and behavioral impact of
genetic counselling and DNA testing for HNPCC on
individuals in high risk families with the MSH2 intron
5 splice site mutation or exon 8 deletion. The data from
confirmed carriers (n=23) were subjected to re-analysis
for the purpose of identifying key barriers to and/or facil-
itators of effective screening and disease management.
Results
Thematic analysis identified personal, health care provi-
der and health care system as the dominant barriers to
and facilitators of screening and disease management.
Person-centered barriers/facilitators included (1) risk
perceptions and decision-making and, (2) enduring
screening/disease management. Provider barriers/facili-
tators were defined in terms of participant perceptions
of physician awareness of the family history of HNPCC,
knowledge of the disease and recommended screening/
treatment protocols, and clinical management skills. The
health care system barriers/facilitators were defined in
terms of continuity of care and coordination of services
among different providers.
Conclusions
Individuals at high risk for HPNCC-related cancers often
encounter multiple barriers to and facilitators of screen-
ing and disease management that go beyond the indivi-
dual and family to the provider and health care system
levels. The current organization and implementation of
health care services for clients who are at high genetic
risk of developing cancer is inadequate. A coordinated
system of local services capable of providing integrated,
efficient health care and follow-up, populated by health
care providers with knowledge of inherited cancer, is
necessary to maintain optimal health in these families.
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